XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1Close
Condensed Consolidated Statements of Income (unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Net sales $ 3,592 $ 3,513
Cost of sales 2,205 2,238
Gross margin 1,387 1,275 Close
Selling, general and administrative expenses 1,027 995 Close
Research and development expenses 176 164 Close
Other operating income, net (3) (13) CloseClose
Total Operating Expenses 1200.0 1146.0 0 0 0 Close
Operating income 187 129 Close
Interest expense, net 78 117 CloseCloseCloseCloseClose
Total Other Income Expenses 85.0 119.0 0.0 0.0 0.0 Close
Total Other Income Expenses -163.0 -236.0 0.0 0.0 0.0 Close CloseClose
Total Other Income Expenses -241.0 -353.0 0.0 0.0 0.0 Close CloseClose
Total Other Income Expenses 163.0 236.0 0.0 0.0 0.0 Close CloseClose
Total Other Income Expenses 85.0 119.0 0.0 0 0 Close CloseClose
Other income, net 7 2 CloseCloseClose
Income from continuing operations before income taxes 116 14 Close
Income tax expense 77 14 Close
Income from continuing operations 39 0
Income from discontinued operations, net of tax 0 45 Close
Net income 39 45 Close
Less: Comprehensive income attributable to noncontrolling interests 2 1
Net income attributable to Baxter stockholders $ 37 $ 44
Income from continuing operations per common share    
Income from continuing operations per common share, basic (in dollars per share) $ 0.07 $ (0.00)
Income from continuing operations per common share, diluted (in dollars per share) 0.07 (0.00)
Income from discontinued operations per common share    
Income from discontinued operations per common share, basic (in dollars per share) 0.00 0.09
Income from discontinued operations per common share, diluted (in dollars per share) 0.00 0.09
Net income per common share    
Basic (in dollars per share) 0.07 0.09
Diluted (in dollars per share) $ 0.07 $ 0.09
Weighted-average number of shares outstanding    
Basic (in shares) 508 505
Diluted (in shares) 510 505